Skip to main content
Immuno-Biological Laboratories Co., Ltd. logo

Immuno-Biological Laboratories Co., Ltd. — Investor Relations & Filings

Ticker · 4570 ISIN · JP3921300004 T Manufacturing
Open in API
Filings indexed 65 across all filing types
Latest filing 2022-06-30 Governance Information
Country JP Japan
Listing T 4570

About Immuno-Biological Laboratories Co., Ltd.

https://www.ibl-japan.co.jp/en/

Immuno-Biological Laboratories (IBL) is a research and development-focused company that develops, manufactures, and supplies immunological research reagents and in-vitro diagnostic products for the global life sciences community. The company's core offerings include a comprehensive range of ELISA kits, antibodies, and cell culture-related products. IBL specializes in several key research areas, including aging, neurodegenerative disorders, kidney diseases, inflammatory diseases, and glucose/lipid metabolism. A notable proprietary technology is the LipoSEARCH® lipoprotein analyzing system, which uses patented GP-HPLC methods. The company also provides customized services to support specific research requirements.

Recent filings

Filing Released Lang Actions
内部統制報告書－第40期(令和3年4月1日－令和4年3月31日)
Governance Information Classification · 100% confidence The document is titled '内部統制報告書' (Internal Control Report) and cites the Financial Instruments and Exchange Act (Article 24-4-4, Paragraph 1). It details the framework, scope, and results of the company's internal control over financial reporting. This type of standalone regulatory report regarding internal controls and audit-related compliance falls under the 'Audit Report / Information' category.
2022-06-30 Japanese
有価証券報告書－第40期(令和3年4月1日－令和4年3月31日)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains comprehensive financial data, management indicators, and business information for the fiscal year ending March 31, 2022. The header explicitly identifies it as a 'Securities Report' (有価証券報告書) submitted under the Financial Instruments and Exchange Act. FY 2022
2022-06-30 Japanese
四半期報告書－第40期第3四半期(令和3年10月1日－令和3年12月31日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan, pursuant to the Financial Instruments and Exchange Act. It contains detailed financial statements, including the balance sheet, income statement, and management analysis for the third quarter of the 40th fiscal period. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2022
2022-02-14 Japanese
訂正四半期報告書－第39期第2四半期(令和2年7月1日－令和2年9月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan, pursuant to the Financial Instruments and Exchange Act. It contains detailed financial statements, management analysis (MDA), and operational data for the second quarter of the 39th fiscal period (April 1, 2020, to September 30, 2020). As it is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial statements, it is classified as an Interim/Quarterly Report. Q2 2021
2021-12-23 Japanese
確認書
Audit Report / Information Classification · 95% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act of Japan. It serves as a formal certification by the CEO regarding the accuracy of a previously filed Annual Securities Report (Yukashoken Hokokusho). Since it is a regulatory filing confirming the validity of financial disclosures and does not fit into specific categories like 10-K or IR, it is classified as a Regulatory Filing. FY 2021
2021-12-22 Japanese
訂正有価証券報告書－第39期(令和2年4月1日－令和3年3月31日)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains comprehensive financial data, including consolidated and non-consolidated financial indicators, balance sheets, and management information for the fiscal year ending March 31, 2021. It is a formal regulatory filing submitted to the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. FY 2021
2021-12-22 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.